A Case Report of a Non-Specific Inflammatory Intra-Thoracic Mass Mimicking Malignancy | Chapter 14 | Current Innovations in Medicine and Medical Science Vol. 5

 A 42- time-old man presented to the exigency department with the complaint of patient cough and hemoptysis. The clinical and radiological findings suggested a low grade malice. An en- bloc resection of the tumour with glutinous casket wall and diaphragm was performed. We were surprised to discover habitualnon-specific inflammation on histology. Although a many benignintra-thoracic lesions have been mentioned to mimic lung cancer, anon-specific seditious mass lesion masquerading as cancer has noway been revealed. Then we bandy the individual and remedial challenges involved in managing this unique clinical reality.

Author(s) Details:

Satya Prakash Meena,
Department of General Surgery, All India Institute of Medical Sciences Jodhpur, India.

Please see the link here: https://stm.bookpi.org/CIMMS-V5/article/view/8472

A Brief Study about Menopause and Gynaecological Malignancy | Chapter 1 | Current Practice in Medical Science Vol. 7

 

 Untimely menopause can happen because of disease treatment. Cervical disease is the most well-known gynecological malignant growth. Constant HPV disease is more normal in postmenopausal ladies. In postmenopausal ladies, HPV immunization plays no part in essential cervical disease anticipation. Cervical disease side effects in postmenopausal ladies are tragically vague and related with co-morbidities. Thus, each indication of cervical malignant growth in a postmenopausal lady ought to be explored completely. Among every single gynecologic disease, ovarian malignant growth is the main source of death. Most of postmenopausal ladies with ovarian malignant growth present with questionable side effects and are in a high level phase of the illness at the hour of show. In the United States, endometrial disease is the most regular gynecologic danger. Most of endometrial carcinomas are identified early and have a positive visualization. However vulvar and vaginal malignant growths are unprecedented, they are normal in postmenopausal ladies. Any postmenopausal lady who has been tingling for quite a while, has a pervaginal release, or has a vulva or vaginal ulcer ought to be assessed completely. So principal objective of this composing is to mindful the gynecological oncologists about the extraordinary parts of gynecological diseases in menopausal lady.

Author(s) Details:

Sabera Khatun,
Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Jannatul Ferdous,
Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Please see the link here: https://stm.bookpi.org/CPMS-V7/article/view/7832

A Clinico-histopathological Analysis on Abnormal Uterine Bleeding | Chapter 14 | Current Practice in Medical Science Vol. 3

The objective of successful care and a better resolution of the issue is the accurate analysis of endometrial samples and localisation of intrauterine lesions. The diagnostic gold standard for the diagnosis of endometrial pathology continues to be the histological features of endometrial biopsy material as evaluated by light microscopy. Patients and gynaecologists frequently deal with abnormal uterine bleeding (AUB). It has a detrimental effect on women's psychological health and quality of life. As one of the causes of anaemia, it is particularly important in poorer nations. Without tissue identification, abnormal uterine bleeding (AUB) therapy is inadequate, especially in perimenopausal and postmenopausal women. Light microscopy-based histological analysis of endometrial biopsy material is still used to make the diagnosis of endometrial pathology. This investigation was prospective and observational. The study included a total of 359 women who were over 45 years old, had abnormal uterine bleeding, and required endometrial curettage. With a p value of 0.01, a significant correlation between the histopathological pattern and hypertension was discovered. Patients with atrophic endometrium, endometrial hyperplasia, and endometrial cancer had higher rates of hypertension (12 out of 20, 68 out of 96, and 14 out of 23 patients, respectively). Endometrial hyperplasia was seen in 68 out of 116 individuals with hypertension. We discovered that multiparous women had the highest prevalence of AUB. The majority of individuals with AUB had endometrial hyperplasia, according to clinicohistopathological examination.

Author(s) Details:

Y. Anupama Suresh,

Department of OBG, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, India.

Y. V. Suresh,

Department of Anesthesiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, India.

Prachi Jain,

Department of OBG, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, India.

Please see the link here: https://stm.bookpi.org/CPMS-V3/article/view/7392

Study on Gynaecological Malignant Tumours at a University Teaching Hospital in Imo State South-Eastern Nigeria | Chapter 14 | New Frontiers in Medicine and Medical Research Vol. 2

 Background: Gynecological malignancies are important components of reproductive health and contribute significantly to morbidity and mortality in women. They may be found all over the world, though the distribution varies depending on the locale.

The goal of this study was to determine the frequency and pattern of gynaecological cancers at a University Teaching Hospital in South Eastern Nigeria.

Methodology: All patients with histologically established genital tract malignancies in the Department of Obstetrics and Gynecology of a University Teaching Hospital in South Eastern Nigeria were retrospectively examined from January 1, 2004 to December 31, 2013.

Cervical cancer accounted for 60.1 percent (131/218) of the 218 cases, followed by ovarian cancer (20.6 percent) (45/218), corpus uteri cancer (10.6%) (23/218), vulval cancer (8.2%) (18/218), and vaginal cancer (0.5 percent) (1/218). Overall, the age range was 30-69, with a large concentration in the 40-49 age group. Cervical and ovarian cancers were the most common cancers among people aged 40 to 49 years old, accounting for 39.7% and 24.5 percent of all cancers, respectively. At the extremes of age (between 20 and 70 years), gynaecological cancers appear to be less common.

Conclusion: Cervical cancer was the most common type of gynaecological cancer in our study. Despite being the most preventable of all gynaecological malignancies and the leading cause of morbidity and mortality in Nigeria, it remains a major cause of morbidity and mortality. To stop this dreadful trend, health education, public awareness, and sound government policies are essential.

Author (S) Details

J. C. Umeobika
Department of Obstetrics and Gynaecology, Chukwuemeka Odumegwu Ojukwu University Teaching Hospital (COOUTH), Awka, Anambra State, Nigeria.

E. C. Ojiyi
Department of Obstetrics and Gynaecology, Imo State University Teaching Hospital (IMSUTH), Orlu, Imo State, Nigeria.

View Book :- https://stm.bookpi.org/NFMMR-V2/article/view/2687

A Case Report on Torsion of Dermoid Cyst in a Perimenopausal Woman | Chapter 14 | Highlights on Medicine and Medical Science Vol. 17

 The Torsion of a Dermoid Cyst in a Perimenopausal Woman is the subject of this case study. Mature cystic teratomas are responsible for 20% to 30% of all ovarian tumours. Patients between the ages of 20 and 40 are the most likely to develop them, and they are usually asymptomatic. Cancer is more common in the perimenopausal and postmenopausal groups. The authors describe a case of dermoid cyst torsion in a 45-year-old perimenopausal woman who presented with acute stomach pain. A 45-year-old perimenopausal woman complained of a lower stomach ache that lasted 8 hours and 3-4 episodes of vomiting. Palpation of an abdomino-pelvic mass comparable to the size of a 28-week-pregnant uterus revealed a regular, firm to cystic, painful mass. On abdominal ultrasonography, a right ovarian cyst measuring 12.9x12.8x10.1 cm was detected. A complete abdominal hysterectomy and bilateral salpingo oopherectomy were performed. A developed cystic teratoma was discovered during a histological examination. Although mature cystic teratomas are uncommon beyond 40 years of age, particularly in perimenopausal women, and are frequently malignant in that age range, they might present at an unusually young age of 45 years and be benign, as in this case.

Author (S) Details

Kondareddy Radhika
Department of Obstetrics and Gynecology, Sri Devaraj Urs Medical College, Kolar, Karnataka, India.

Sonam Singh
Department of Obstetrics and Gynecology, Sri Devaraj Urs Medical College, Kolar, Karnataka, India.

M. Munikrishna
Department of Obstetrics and Gynecology, Sri Devaraj Urs Medical College, Kolar, Karnataka, India.

View Book :- https://stm.bookpi.org/HMMS-V17/article/view/2617

Granulomatous Lobular Mastitis: A Clinicopathological Study | Chapter 4 | Highlights on Medicine and Medical Science Vol. 17

 Granulomatous Lobular Mastitis is a rather uncommon illness. This condition resembles cancer and tuberculosis. This syndrome is characterised by granulomatous inflammation with multinucleated large cells and epithelioid histiocytes. The inflammation is concentrated in the lobules. The purpose of this study is to look at the clinical and pathological features of eight cases of granulomatous lobular mastitis, as well as the literature.

The research is based on a prospective observational study. There were a total of eight patients examined. The investigations are now concluded. The patient was given Erythromycin 250 mg qid for seven days, Tinidazole 500 mg bid for two months, and steroids for seven days. After the tumours were removed, the sinuses were excised, and the abscesses were drained, oral steroids were given. There was a six-month follow-up.

The patients, who ranged in age from 18 to 36, were usually multiparous and nursing. In three cases, the lesion was found to be malignant, while in five others, it was found to be benign. Oral contraceptive tablets were used by the majority of the patients. In three cases, suppuration was observed, while sinuses were discovered in two others. On histological examination, a granulomatous inflammation centred on the lobules was found.

Conclusion: The diagnosis of granulomatous lobular mastitis should be established very carefully to avoid misunderstandings with malignancy, tuberculosis, fungal infection, sarcoidosis, mammary duct ectasia, cystic abnormalities in the breast with over palpation, and puerperal mastitis with over palpation. Despite its rarity, pathologists and surgeons must have a solid understanding of the disease in order to better its identification.

Author (S) Details

Sapna Goel
Department of Pathology, SHKM Government Medical college, Nalhar, Nuh, Mewat, Haryana, India.

Kanwar Singh Goel
Department of General Surgery, Faculty of Medicine & Health Sciences, (SGT Medical College) Under SGT University, Budhera, Gurugram, Haryana, India.

View Book :- https://stm.bookpi.org/HMMS-V17/article/view/2607

Butterfly Gastric Bypass | Chapter 2 | Highlights on Medicine and Medical Science Vol. 7

 Perforation, haemorrhage, and cancer of the bypassed stomach, duodenum, and biliary tree are significant problems that can be deadly if not detected early, which is difficult with RYGBP and micro bypass procedures. Butterfly gastroplasty is an option for patients who are suitable for bariatric surgery. When comorbidities are present, the BMI should be greater than 30 or greater than 25. The success of butterfly gasroplasty as a laparoscopic restrictive technique, as evidenced by the fact that over 1000 cases have been performed (since 2008) in numerous centres and the Ahmed Maher teaching hospital in Cairo, Egypt. We recommend laparoscopic butterfly gastric bypass (BB) as the treatment of choice for morbid obesity because it combines all of the benefits of a mini gastric bypass with the added benefit of a gastro-gastric banded outlet that allows for easy endoscopic and radiological diagnosis and treatment of the bypassed stomach.

Author (S) Details

Essam Abdel-Galil
Department of Surgery, Ahmed MAHER Teaching Hospital, Cairo, Egypt.

View Book :- https://stm.bookpi.org/HMMS-V7/article/view/2030

Serological Thymidine Kinase1 is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People | Chapter 3 | Newest Updates in Physical Science Research Vol. 5

 STK1p, a serological thymidine kinase 1 (STK1p) proliferation marker, is a reliable prognostic, monitoring, and relapse marker. The application of STK1p in health screening for early diagnosis of pre-malignant and malignant disorders was examined in this study. The research was based on 35,365 people who took part in four separate health screening studies in China from 2005 to 2019 using Real World Data. All of the individuals were given a clinical examination. A sensitive chemiluminescent dot blot ECL assay was used to measure the quantity of STK1p. The STK1p test had a ROC value of 0.96. The likelihood (+) value was 236.5 at a cut-off STK1p value of 2.0 pM, and the sensitivity and specificity were 0.78 and 0.99, respectively. The proportion of city dwellers with elevated STK1p values (>2.0 pM) was 0.8 percent (198/26,484), while the proportion of oil-field employees with elevated STK1p values (>2.0 pM) was 5.8 percent (514/8,355). In comparison to city inhabitants, the latter group had significantly greater rates of refractory anaemia, fatty liver, and obesity, but no incidences of breast or prostate hyperplasia were found. People who worked in oil drilling/transportation also had higher STK1p levels and a greater rate of pre-malignancies and benign illnesses than those who worked in oil-field administration. When comparing people with low STK1p values (2.0 pM) to people with high STK1p values (>2.0 pM), a statistically significantly higher number of people were found to have malignancies, pre-malignancies of all types, moderate/severe type of hyperplasia of breast or prostate, or refractory anaemia, or to be at high risk for hepatitis B. In the STK1p low group, no malignancies were discovered. Compared to 52.4 percent of individuals with low STK1p values, 85.4 percent of those with elevated STK1p values had illnesses linked to a higher risk of pre-/early neoplastic development. Persons with low STK1p levels (n=6,352/26,484) and raised STK1p values (170/702) were randomly selected and followed for 132 months. People with increased STK1p values had a 4 times higher chance of developing malignancies than people with low STK1p values. Based on official cancer statistics in China, the risk value was derived using an expected cancer occurrence incidence of 0.2 percent among people with low STK1p. We conclude that serological TK1 protein concentration is a reliable diagnostic for predicting the likelihood of cancer progression in the early stages.

Author (s) Details

Zhi-Heng Chen
Health Management Centre, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.

Xia Cao
Health Management Centre, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.

Shou-Qing Huang
Healthy Centre of the Affiliated Second Hospital, Fujian Chinese Tradition Medicine University, China.

Guo-zhan Zhao
Jilin Oil Field General Hospital, Jilin 131106, China.

Ai Zeng Yang
Department of Clinical and Laboratory Medicine, Nanjing 81 Hospital, Jiangsu 210002, China.

Jian Wen
Department of Clinical and Laboratory Medicine, Nanjing Tumor Hospital, Nanjing 210011, China.

Xiao-Hong Xu
Department of Clinical and Laboratory Medicine, Zhejiang Cancer Hospital, Hangzhou 310022, China.

Yan Chen
Laboratory of Biochemistry and Molecular Biology Research, Fujian Cancer Hospital of Fujian Medical University Teaching Hospital, Fuzhou 350014, China.

Qu-Bo Chen
Chinese Medicine Hospital, Guangdong 510120, China.

Ying-Hong Wang
Central Laboratory, Cancer Institute & Hospital, Chinese Academy of Medical Sciences (CAMS), Beijing 100021, China.

Ellen He
Shenzhen SSTK Precision Medicine Institute, Shenzhen 518057, China.

Ji Zhou
Shenzhen SSTK Precision Medicine Institute, Shenzhen 518057, China.

Sven Skog
Shenzhen SSTK Precision Medicine Institute, Shenzhen 518057, China.

View Book :- https://stm.bookpi.org/NUPSR-V5/article/view/1398